Open-heart surgery has been the status quo for a long time, and for younger patients, it works. The problem is, seniors, a group of people more likely to be afflicted by a heart ailment, are much less likely to survive the procedure. But a recent trial of a new technique might be a better alternative: A team at Monash Medical Centre in Melbourne has successfully replaced heart valves in 11 elderly women without going open-heart.
The women all suffered from aortic stenosis, a disease that narrows the heart's main valve. Doctors used a replacement valve called a "lotus valve" that can be attached to the end of a wire and fed into the heart. Once it's there, it unfolds and starts working. All 11 of the women made it through the process.
That's really good news. Right now, only about a third of elderly people live for two years with aortic stenosis. We'll wait and see what kind of wider release and use the lotus valve gets; the next trial run will have 16 facilities in four countries using the valve.
The incredible innovations, like drone swarms and perpetual flight, bringing aviation into the world of tomorrow. Plus: today's greatest sci-fi writers predict the future, the science behind the summer's biggest blockbusters, a Doctor Who-themed DIY 'bot, the organs you can do without, and much more.


Online Content Director: Suzanne LaBarre | Email
Senior Editor: Paul Adams | Email
Associate Editor: Dan Nosowitz | Email
Assistant Editor: Colin Lecher | Email
Assistant Editor: Rose Pastore | Email
Contributing Writers:
Kelsey D. Atherton | Email
Francie Diep | Email
Shaunacy Ferro | Email
An Aortic valve can be replaced by artificial means as as prosthesis made of polycarboxalte and a silicon gel as a bio compatible material and thus has a low risk of rejection by body,the discovery of LOTUS Valve in cases of aortic stenosis or other valve involving the chordae tendonae or cardiac muscle in general at the nodal or at interclacted discs can be best treated within the consideration of Lotus Valve for a survival of person with cardiac atrophy.
The first? Far from it. The Medtronic CoreValve and Edwards Sapien have been in use for quite some time. Also, there is a reason the trial is all women. This particular transcatheter valve is too small to properly treat a large portion of the population.